Logo image of CRE.CA

CRITICAL ELEMENTS LITHIUM CO (CRE.CA) Stock Fundamental Analysis

TSX-V:CRE - TSX Venture Exchange - CA22675W1077 - Common Stock - Currency: CAD

0.4  0 (0%)

Fundamental Rating

3

CRE gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 802 industry peers in the Metals & Mining industry. CRE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CRE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year CRE was profitable.
In the past year CRE has reported a negative cash flow from operations.
CRE had negative earnings in each of the past 5 years.
In the past 5 years CRE always reported negative operating cash flow.
CRE.CA Yearly Net Income VS EBIT VS OCF VS FCFCRE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

With an excellent Return On Assets value of 11.51%, CRE belongs to the best of the industry, outperforming 94.39% of the companies in the same industry.
CRE's Return On Equity of 12.36% is amongst the best of the industry. CRE outperforms 93.64% of its industry peers.
Industry RankSector Rank
ROA 11.51%
ROE 12.36%
ROIC N/A
ROA(3y)-4.68%
ROA(5y)-5.01%
ROE(3y)-5.12%
ROE(5y)-5.89%
ROIC(3y)N/A
ROIC(5y)N/A
CRE.CA Yearly ROA, ROE, ROICCRE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5 -10 -15 -20

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CRE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CRE.CA Yearly Profit, Operating, Gross MarginsCRE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

6

2. Health

2.1 Basic Checks

Compared to 1 year ago, CRE has about the same amount of shares outstanding.
Compared to 5 years ago, CRE has more shares outstanding
The debt/assets ratio for CRE has been reduced compared to a year ago.
CRE.CA Yearly Shares OutstandingCRE.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CRE.CA Yearly Total Debt VS Total AssetsCRE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 8.04 indicates that CRE is not in any danger for bankruptcy at the moment.
CRE has a Altman-Z score of 8.04. This is in the better half of the industry: CRE outperforms 72.69% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that CRE is not too dependend on debt financing.
CRE's Debt to Equity ratio of 0.00 is in line compared to the rest of the industry. CRE outperforms 56.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 8.04
ROIC/WACCN/A
WACCN/A
CRE.CA Yearly LT Debt VS Equity VS FCFCRE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

A Current Ratio of 15.42 indicates that CRE has no problem at all paying its short term obligations.
CRE's Current ratio of 15.42 is amongst the best of the industry. CRE outperforms 90.15% of its industry peers.
A Quick Ratio of 15.42 indicates that CRE has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 15.42, CRE belongs to the best of the industry, outperforming 90.15% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 15.42
Quick Ratio 15.42
CRE.CA Yearly Current Assets VS Current LiabilitesCRE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

2

3. Growth

3.1 Past

CRE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 312.67%, which is quite impressive.
EPS 1Y (TTM)312.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%927.91%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

CRE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 88.11% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-22%
EPS Next 2Y37.48%
EPS Next 3Y236.2%
EPS Next 5Y88.11%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CRE.CA Yearly Revenue VS EstimatesCRE.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 2029 100M 200M 300M 400M 500M
CRE.CA Yearly EPS VS EstimatesCRE.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.2 0.4 0.6

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 8.00, the valuation of CRE can be described as very reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of CRE indicates a rather cheap valuation: CRE is cheaper than 95.64% of the companies listed in the same industry.
CRE's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.21.
CRE is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 8
Fwd PE N/A
CRE.CA Price Earnings VS Forward Price EarningsCRE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CRE.CA Per share dataCRE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3

4.3 Compensation for Growth

CRE's earnings are expected to grow with 236.20% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.48%
EPS Next 3Y236.2%

More info and screens

0

5. Dividend

5.1 Amount

CRE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CRITICAL ELEMENTS LITHIUM CO

TSX-V:CRE (5/9/2025, 7:00:00 PM)

0.4

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)04-28 2025-04-28
Earnings (Next)07-07 2025-07-07
Inst Owners3.24%
Inst Owner ChangeN/A
Ins Owners4.27%
Ins Owner ChangeN/A
Market Cap87.14M
Analysts83.08
Price Target1.49 (272.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.35%
PT rev (3m)0.69%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-25.84%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 8
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.05
P/tB 1.05
EV/EBITDA N/A
EPS(TTM)0.05
EY12.5%
EPS(NY)0
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS0.38
TBVpS0.38
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 11.51%
ROE 12.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.68%
ROA(5y)-5.01%
ROE(3y)-5.12%
ROE(5y)-5.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 8570.9%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 15.42
Quick Ratio 15.42
Altman-Z 8.04
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)12312.4%
Cap/Depr(5y)9260.33%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)312.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%927.91%
EPS Next Y-22%
EPS Next 2Y37.48%
EPS Next 3Y236.2%
EPS Next 5Y88.11%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-23.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-322.62%
EBIT Next 3Y132.14%
EBIT Next 5Y123.6%
FCF growth 1Y18.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y9.73%
OCF growth 3YN/A
OCF growth 5YN/A